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The ever-mounting pressure on surgeons to improve 
efficacy, safety and financial outcomes of their work, 
has driven them, and the industry, to seek ways for 
enhancing operative precision. We certainly need to 
delineate, beyond doubt, lesions that are supposed to 
be completely removed, as well as structures that 
ought to be preserved. One way to achieve this goal is 
to augment visualization at surgery using fluorescence 
techniques. The concept of fluorescence-guided 
surgery is based on making the target tissue shine by 
light emanating from within, thus standing out in the 
operative field more prominently, while the surgeon is 
actually at work, i.e., offering real-time augmented 
visualization. 
Simply put, the principle is based on preferentially 
delivering a fluorescent material, a fluorophore, to the 
target tissue, followed by exposing the operative field 
to excitation light of a particular wavelength that lies 
in the invisible spectrum. Excitation of the fluorophore 
results in emission of a different light, a phenomenon 
that is called fluorescence. Emitted light is either 
visible and is picked up by the naked eye, or invisible 
and requires a special camera to see. 
During the last decade, the surgical literature has 
witnessed a persistently growing number of 
publications addressing this evolving technology. 
Most of them have investigated the use of the 
fluorophore indocyanine green (ICG), which is excited 
by near-infrared (NIR) light. Popularity of this light is 
due to its tissue penetration to a depth that exceeds the 
conventional white light as it may reach down to 1cm. 
It, thus, allows the real-time vision of the operator to 
reach beneath the surface, albeit for no more than a 
centimetre. Two other fluorophores are in common 
use. These are fluorescein and 5-aminolevulinic acid 
(5-ALA). 
The technology made its best impact in the field of 
cancer surgery. In this field ensuring complete cancer 
excision, meanwhile reducing collateral damage is the 
sine qua non for success. Success with making cancers 
fluoresce is based on the fact that the leaky nature of 
tumour vessels allows a fluorophore to gain a higher 
concentration in its tissues. Among the different types 
of studied malignancies, two have shown that 
fluorescence guidance is of notable value. Removal of 
intracranial gliomas under 5-ALA guidance has 
demonstrated that the real extension of the tumour is 
likely to be beyond that identified by MRI (1). Equally 
good, several research articles have attested to the 
added value of ICG/NIR for precisely locating liver 
tumours, intraoperatively (2). Furthermore, boosting 
precision of cancer localization can be achieved by 
selective targeting where the fluorophore is bound to a 
molecule that has avidity for certain neoplastic tissue. 
The first clinical example of this refinement was 
published in 2013 where conjugating folate with 
fluorescein allowed van Dam et al. very clear 
visualization of ovarian cancer deposits in the 
peritoneal cavity (3). 
The new technology has also found its way for 
locating sentinel lymph nodes (SLN) in cases of breast 
cancer and melanoma surgery. Case series studies 
proved its feasibility and safety. It was also studied for 
accuracy either in its own or in combination with other 
modalities. A 2014 randomized controlled trial (4) 
compared blue dye with fluorescence technique for 
breast cancer SLN where ICG/NIR fluorescence 
proved to give a significantly higher detection rate. 
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Outside the field of cancer surgery, the list of 
operative fluorescence guidance is long, yet two 
examples of popular operations are worth mentioning, 
namely cholecystectomy and intestinal resection. 
While intraoperative cholangiography (IOC) is the 
standard method for delineating bile duct anatomy at 
cholecystectomy, the technique is not perfect. It 
involves ionizing radiation and entails exhausting 
mental work in order to adapt the radiographic image 
to what the surgeon actually sees on a laparoscopy 
screen. Consequently, such adaptation is commonly 
inaccurate. Fluorescence guidance promises to fill this 
gap with its safety and real-time augmented 
visualization of the ducts. Multiple studies verified the 
efficacy and safety of ICG/NIR for ductal delineation. 
Others concluded that it could shorten operative time 
(5) while being easier to use and is less costly than 
IOC (6). Further less expensive and simpler 
fluorescent technology using fluorescein and 
ultraviolet light has more recently evolved. As the 
emitted light is within the visible spectrum it requires 
no special cameras to detect. The technique proved to 
be 100% specific and 82.5% sensitive for locating bile 
duct (7). 
While fluorescence-guided cholecystectomy is new, 
fluorescence for assessing intestinal viability dates 
back to the mid 20th century. An intravenously 
administered fluorophore will reach vascularized 
segments and will fluoresce under excitation light 
while non-vascularized segments will not. The 
technique would, thus, guide the surgeon to the extent 
of resection and helps judge viability of an 
anastomosis. With the recent technological advances, 
the use of this principle has been revived, particularly 
with robotic resection of rectal cancer, a site that is 
known for a notoriously high leakage rate. Initial 
reports revealed encouraging results (8,9). 
Fluorescence-guided surgery suffers two weak points. 
The first is technical, which is limited penetration of 
the excitation light. Some may argue that this point 
might not be a significant obstacle because the surgeon 
will bring the tissue of interest closer to the surface 
during dissection. A more practical solution is 
combining fluorescence with another technique, e.g., 
ultrasound, Magnetic Resonance Imaging (MRI) or 
Positron Emission Tomography (PET) scan. The other 
weak point that actually slows down its routine use in 
surgical practice is that most of the relevant research is 
not of high evidence level. In fact, only a few 
randomized controlled trials were published. This is 
clearly a problem that will be solved with time, as 
more high-quality research will be generated. 
The advantages of this technology certainly outnumber 
its disadvantages. The main one is the real-time 
augmentation of the surgeon’s vision. The target 
becomes visually more prominent in the operative 
field. Other strong points include simplicity, fair 
efficacy and safety. In addition, it is relatively new and 
is; therefore, open to research and development. The 
expectation is that “fluorescence-guided surgery is 
here to stay and mature”.   
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